Evidence map›Paper›PMID 17360627›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2.

Daniel W Young, Mohammad Q Hassan, Xiao-Qing Yang, Mario Galindo, Amjad Javed, Sayyed K Zaidi, Paul Furcinitti, David Lapointe, Martin Montecino, Jane B Lian and 3 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Daniel W YoungDepartment of Cell Biology and Cancer Center, Program in Molecular Medicine, and Information Services, University of Massachusetts Medical School, Worcester, MA 01655-0105, USA.
Mohammad Q Hassan
Xiao-Qing Yang
Mario Galindo
Amjad Javed
Sayyed K Zaidi
Paul Furcinitti
David Lapointe
Martin Montecino
Jane B Lian
Janet L Stein
Andre J van Wijnen
Gary S Stein
University of Massachusetts Chan Medical School · USNational Cancer Center · USOrthopedic One · USUniversity of Concepción · CL

Funding

SUBNUCLEAR TARGETING OF TRANSCRIPTION FACTORSP01CA082834 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 2001 to 2015
$18.4M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Subnuclear Integration of Regulatory Signals Controlling Bone Cell FunctionP01AR048818 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, JANET L · 2002 to 2011
$14.0M
CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
RHEUMATOLOGY RESEARCH TRAINING PROGRAMST32AR007572 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZURIER, ROBERT B · 1993 to 2003
$491k
NCI NIH HHS P01 CA082834NCI NIH HHS P01CA82834NIAMS NIH HHS AR049069NIAMS NIH HHS AR39588NIAMS NIH HHS P01 AR048818NIAMS NIH HHS P01AR48818NIAMS NIH HHS R01 AR039588NIAMS NIH HHS R01 AR049069NIAMS NIH HHS T32 AR007572NIAMS NIH HHS T32 AR07572NIDDK NIH HHS P30 DK032520NIDDK NIH HHS P30 DK32520
6 · The paper itself

Abstract

During cell division, cessation of transcription is coupled with mitotic chromosome condensation. A fundamental biological question is how gene expression patterns are retained during mitosis to ensure the phenotype of progeny cells. We suggest that cell fate-determining transcription factors provide an epigenetic mechanism for the retention of gene expression patterns during cell division. Runx proteins are lineage-specific transcription factors that are essential for hematopoietic, neuronal, gastrointestinal, and osteogenic cell fates. Here we show that Runx2 protein is stable during cell division and remains associated with chromosomes during mitosis through sequence-specific DNA binding. Using siRNA-mediated silencing, mitotic cell synchronization, and expression profiling, we identify Runx2-regulated genes that are modulated postmitotically. Novel target genes involved in cell growth and differentiation were validated by chromatin immunoprecipitation. Importantly, we find that during mitosis, when transcription is shut down, Runx2 selectively occupies target gene promoters, and Runx2 deficiency alters mitotic histone modifications. We conclude that Runx proteins have an active role in retaining phenotype during cell division to support lineage-specific control of gene expression in progeny cells.

Indexed as

Blotting, WesternCell DifferentiationCell Line, TumorChromatin ImmunoprecipitationChromosomes, HumanCore Binding Factor Alpha 1 SubunitElectrophoretic Mobility Shift AssayEpigenesis, GeneticGene Expression ProfilingGene Expression RegulationHumansMicroscopy, FluorescenceMitosisPromoter Regions, GeneticRNA InterferenceCore Binding Factor Alpha 1 SubunitRUNX2 protein, human

Identifiers

PMID17360627
PMCPMC1805558
OpenAlexW1999538541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.